These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 7013721)

  • 41. [Treatment of ventricular arrhythmias after acute myocardial infarct with procaine amide and mexiletine].
    Dolder M; Campbell RW; Talbot RG; Murray A; Prescott LE; Julian DG
    Adv Clin Pharmacol; 1978; 16():59-70. PubMed ID: 356554
    [No Abstract]   [Full Text] [Related]  

  • 42. The role of antiarrhythmic drugs in prevention of sudden cardiac death.
    Podrid PJ
    Cardiovasc Clin; 1985; 15(3):265-86. PubMed ID: 2421903
    [No Abstract]   [Full Text] [Related]  

  • 43. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.
    Hirotsu I; Kihara T; Nakamura S; Hattori Y; Hatta M; Kitakaze Y; Takahama K; Hashimoto Y; Miyata T; Ishihara T
    Arzneimittelforschung; 1988 Oct; 38(10):1398-409. PubMed ID: 3196380
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical antiarrhythmic efficacy of mexiletine: a review.
    Kulbertus HE
    Acta Cardiol Suppl; 1980; (25):111-20. PubMed ID: 6990663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mexiletine: long-term efficacy and hemodynamic actions in patients with ventricular arrhythmia.
    Sami M; Lisbona R
    Can J Cardiol; 1985; 1(4):251-8. PubMed ID: 2413974
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The effect of mexiletine, ajmaline and aprindine on ventricular arrhythmias].
    Pozenel H
    Adv Clin Pharmacol; 1978; 16():125-37. PubMed ID: 356551
    [No Abstract]   [Full Text] [Related]  

  • 47. Long term treatment of ventricular arrhythmias with oral mexiletine.
    Campbell RW; Julian DG; Talbot RG; Prescott LF
    Postgrad Med J; 1977; 53 Suppl 1():146-9. PubMed ID: 406605
    [No Abstract]   [Full Text] [Related]  

  • 48. Efficacy of mexiletine in chronic ventricular arrhythmias: a multicentre double-blind medium-term trial.
    Poggesi L; Scarti L; Ieri A; Lanzetta T; Grazzini M; Del Bene P; Masini G; Del Citerna F; Carnovali M; Masotti G
    Int J Clin Pharmacol Res; 1989; 9(4):269-75. PubMed ID: 2476406
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of rhythm disorders of ventricular origin with KO 1173 (Mexiletin) (author's transl)].
    Esser H; Kikis D
    Med Klin; 1977 Sep; 72(35):1386-91. PubMed ID: 71652
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long term oral antiarrhythmic therapy with mexiletine.
    Campbell NP; Shanks RG; Kelly JG; Adgey AA
    Postgrad Med J; 1977; 53 Suppl 1():143-5. PubMed ID: 406604
    [No Abstract]   [Full Text] [Related]  

  • 51. Paediatric use of mexiletine and disopyramide.
    Holt DW; Walsh AC; Curry PV; Tynan M
    Br Med J; 1979 Dec; 2(6203):1476-7. PubMed ID: 526816
    [No Abstract]   [Full Text] [Related]  

  • 52. Antiarrhythmic efficacy of penticainide and comparison with disopyramide, flecainide, propafenone and mexiletine by acute oral drug testing.
    Priori SG; Bonazzi O; Facchini M; Varisco T; Schwartz PJ
    Am J Cardiol; 1987 Nov; 60(13):1068-72. PubMed ID: 3118693
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized, double-blind, parallel group comparison of disopyramide phosphate and quinidine in patients with cardiac arrhythmias.
    Arif M; Laidlaw JC; Oshrain C; Willis PW; Nissen CH; McDermott DJ; Smith WS; Karim A; Wilson RR
    Angiology; 1983 Jun; 34(6):393-400. PubMed ID: 6408949
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effectiveness of mexiletine in ventricular arrhythmias.
    Chaudron JM; Luwaert RJ
    Acta Cardiol; 1985; 40(6):589-98. PubMed ID: 2420104
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Disopyramide--an effective treatment for lignocaine resistant ventricular dysrhythmias.
    Green AG
    Scott Med J; 1979 Jan; 24(1):21-4. PubMed ID: 91197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of mexiletine in chronic ventricular arrhythmias compared with quinidine: a single-blind, randomized trial.
    Singh JB; Rasul AM; Shah A; Adams E; Flessas A; Kocot SL
    Am J Cardiol; 1984 Jan; 53(1):84-7. PubMed ID: 6362388
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Drug therapy of arrhythmia in coronary cardiopathy].
    Lüderitz B
    Clin Ter; 1983 Apr; 105(1):3-11. PubMed ID: 6189663
    [No Abstract]   [Full Text] [Related]  

  • 59. Efficacy of mexiletine in the medium-term treatment of ventricular arrhythmias. A randomized, double-blind, crossover trial against placebo in ambulatory patients.
    Masotti G; Morettini A; Casolo GC; Ieri A; Zipoli A; Serneri GG
    J Int Med Res; 1984; 12(2):73-80. PubMed ID: 6202571
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mexiletine, a new antiarrhythmic agent, for treatment of premature ventricular complexes.
    Mehta J; Conti CR
    Am J Cardiol; 1982 Feb; 49(2):455-60. PubMed ID: 6174042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.